Advertisement
Journal Home
Search for

Volume 35, Issue 3, Pages 157-162 (April 2007)


View previous. 8 of 18 View next.

A point prevalence survey of health care–associated infections in pediatric populations in major Canadian acute care hospitals

Denise Gravel, BScN, MSc, CICaCorresponding Author Informationemail address, Anne Matlow, MDb, Marianna Ofner-Agostini, RN, PhDa, Mark Loeb, MDc, Lynn Johnston, MDd, Elizabeth Bryce, MDe, Mary Lu Sample, RN, CICf, Virginia R. Roth, MDf, Carol Goldman, RN, CICb, Geoff Taylor, MDg, the Canadian Nosocomial Infection Surveillance Program

Objective

To estimate the prevalence of pediatric health care–associated infections (HAI) in Canadian acute care hospitals.

Methods

A point-prevalence study conducted in February 2002 in 25 hospitals across Canada. Information on HAI, utilization of antimicrobial agents and invasive devices, isolation precautions, and microbial etiology was collected.

Results

Nine hundred ninety-seven children were surveyed. Ninety-one HAI were detected in 80 patients for a prevalence of 91 per 1000 patients surveyed. Bloodstream infections were the most common HAI (3% of patients; 34% of all HAI). The prevalence of patients with HAI was 8%, ranging from 0% in trauma/bum units to 19% in the pediatric intensive care units, and 27% in transplant units. By multivariate logistic regression analysis, having a central venous catheter (OR, 2.54; 95% CI, 1.46-4.40) or endotracheal tube with mechanical ventilation (OR, 2.59; 95% CI, 1.16-5.76) were independently associated with an HAI, as were being in isolation (OR, 2.90; 95% CI, 1.54-5.45), and receiving antimicrobial agents (OR, 9.27; 95% CI, 4.71-18.52).

Conclusion

In this first national point-prevalence study in Canada, the prevalence of HAI was similar to that reported in other industrialized countries. These data will also be useful to provide an estimate of the health burden of pediatric HAI in Canada.

Ottawa, Toronto, Hamilton, Halifax, Vancouver, and Edmonton, Canada

a From the Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, Ottawa, ON

b Hospital for Sick Children, Toronto, ON

c Hamilton Health Sciences Corporation, Hamilton, ON

d QEII Health Sciences Centre, Halifax, NS

e Vancouver General Hospital, Vancouver, BC

f The Ottawa Hospital, Ottawa, ON

g University of Alberta Hospital, Edmonton, AB, Canada

Corresponding Author InformationAddress correspondence to Denise Gravel, BScN, MSc, CIC, Nosocomial and Occupational Infections Section, Blood Safety and Surveillance, Health-Care Acquired Infections Division, Public Health Agency of Canada, Tunney's Pasture, PL 0601E2, Ottawa, Ontario, K1A 0L2, Canada.

PII: S0196-6553(06)01103-5

doi:10.1016/j.ajic.2006.06.006


View previous. 8 of 18 View next.